What to expect when you take Ceftin and Metformin hydrochloride?

Do you take Ceftin and Metformin hydrochloride? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 10, 2019

48,753 reports have been studied.


Females aged 50 to 59 :

27,474 related reports were analyzed:

Most common symptoms:

Abdominal pain
  • 8.96% for females aged 50 (±5) who take Ceftin
Acute kidney failure
  • 7.46% for females aged 50 (±5) who take Ceftin
Anaemia
  • 11.94% for females aged 50 (±5) who take Ceftin
Appendicitis
  • 6.18% for females aged 50 (±5) who take Ceftin
Aptyalism
  • 5.97% for females aged 50 (±5) who take Ceftin
Asthma
  • 6.4% for females aged 50 (±5) who take Ceftin
Atelectasis
  • 5.33% for females aged 50 (±5) who take Ceftin
Back pain
  • 5.97% for females aged 50 (±5) who take Ceftin
Blood glucose increased
  • 10.95% for females aged 50 (±5) who take Metformin hydrochloride
Bone disorder
  • 6.4% for females aged 50 (±5) who take Ceftin
Bone erosion
  • 5.97% for females aged 50 (±5) who take Ceftin
Bone fragmentation
  • 5.97% for females aged 50 (±5) who take Ceftin
Bone pain
  • 7.46% for females aged 50 (±5) who take Ceftin
Bronchitis
  • 5.33% for females aged 50 (±5) who take Ceftin
Cellulitis
  • 6.4% for females aged 50 (±5) who take Ceftin
Chest pain
  • 7.68% for females aged 50 (±5) who take Ceftin
Deep venous thrombosis
  • 5.12% for females aged 50 (±5) who take Ceftin
Dental caries
  • 5.97% for females aged 50 (±5) who take Ceftin
Depression
  • 9.17% for females aged 50 (±5) who take Ceftin
Diarrhea
  • 13.22% for females aged 50 (±5) who take Ceftin
  • 6.23% for females aged 50 (±5) who take Metformin hydrochloride
Diverticulum
  • 8.53% for females aged 50 (±5) who take Ceftin
Dizziness
  • 5.54% for females aged 50 (±5) who take Ceftin
  • 5.21% for females aged 50 (±5) who take Metformin hydrochloride
Drug hypersensitivity
  • 9.81% for females aged 50 (±5) who take Ceftin
Dyspnea
  • 5.97% for females aged 50 (±5) who take Ceftin
Enteritis
  • 5.97% for females aged 50 (±5) who take Ceftin
Enterococcal infection
  • 5.97% for females aged 50 (±5) who take Ceftin
Escherichia infection
  • 5.97% for females aged 50 (±5) who take Ceftin
Essential thrombocythaemia
  • 5.97% for females aged 50 (±5) who take Ceftin
Exostosis
  • 8.53% for females aged 50 (±5) who take Ceftin
Facial neuralgia
  • 5.97% for females aged 50 (±5) who take Ceftin
Fall
  • 5.97% for females aged 50 (±5) who take Ceftin
Fatigue
  • 11.73% for females aged 50 (±5) who take Ceftin
  • 5.96% for females aged 50 (±5) who take Metformin hydrochloride
Fever
  • 10.87% for females aged 50 (±5) who take Ceftin
Foot fracture
  • 6.61% for females aged 50 (±5) who take Ceftin
Gastroesophageal reflux disease
  • 11.51% for females aged 50 (±5) who take Ceftin
Generalised oedema
  • 5.97% for females aged 50 (±5) who take Ceftin
Gingival infection
  • 5.97% for females aged 50 (±5) who take Ceftin
Gingival pain
  • 5.97% for females aged 50 (±5) who take Ceftin
Gingivitis
  • 5.97% for females aged 50 (±5) who take Ceftin
Gums - swollen
  • 5.97% for females aged 50 (±5) who take Ceftin
Haemangioma
  • 5.97% for females aged 50 (±5) who take Ceftin
Headache
  • 6.61% for females aged 50 (±5) who take Ceftin
  • 5.33% for females aged 50 (±5) who take Metformin hydrochloride
Hiatal hernia
  • 5.33% for females aged 50 (±5) who take Ceftin
Humerus fracture
  • 5.76% for females aged 50 (±5) who take Ceftin
Hypoaesthesia
  • 7.04% for females aged 50 (±5) who take Ceftin
Hypotension
  • 5.12% for females aged 50 (±5) who take Ceftin
Injury
  • 7.25% for females aged 50 (±5) who take Ceftin
Intervertebral disc degeneration
  • 6.61% for females aged 50 (±5) who take Ceftin
Intervertebral disc protrusion
  • 6.82% for females aged 50 (±5) who take Ceftin
Joint dislocation
  • 5.76% for females aged 50 (±5) who take Ceftin
Joint pain
  • 6.61% for females aged 50 (±5) who take Ceftin
Lung disorder
  • 6.18% for females aged 50 (±5) who take Ceftin
Malocclusion
  • 5.97% for females aged 50 (±5) who take Ceftin
Metastatic neoplasm
  • 7.46% for females aged 50 (±5) who take Ceftin
Mouth ulcers
  • 6.18% for females aged 50 (±5) who take Ceftin
Nasal congestion
  • 5.12% for females aged 50 (±5) who take Ceftin
Nausea
  • 14.07% for females aged 50 (±5) who take Ceftin
  • 12.52% for females aged 50 (±5) who take Metformin hydrochloride
Nausea and vomiting
  • 6.18% for females aged 50 (±5) who take Metformin hydrochloride
  • 5.33% for females aged 50 (±5) who take Ceftin
Oedema peripheral
  • 9.81% for females aged 50 (±5) who take Ceftin
Osteitis
  • 5.97% for females aged 50 (±5) who take Ceftin
Osteoarthritis
  • 8.53% for females aged 50 (±5) who take Ceftin
Osteolysis
  • 5.97% for females aged 50 (±5) who take Ceftin
Osteomyelitis
  • 8.1% for females aged 50 (±5) who take Ceftin
Osteonecrosis of jaw
  • 9.81% for females aged 50 (±5) who take Ceftin
Osteopenia
  • 9.38% for females aged 50 (±5) who take Ceftin
Osteoporosis
  • 9.81% for females aged 50 (±5) who take Ceftin
Otitis externa
  • 5.12% for females aged 50 (±5) who take Ceftin
Paget's disease
  • 5.97% for females aged 50 (±5) who take Ceftin
Pain
  • 19.19% for females aged 50 (±5) who take Ceftin
Pain in jaw
  • 6.4% for females aged 50 (±5) who take Ceftin
Periodontal disease
  • 5.97% for females aged 50 (±5) who take Ceftin
Periodontitis
  • 5.97% for females aged 50 (±5) who take Ceftin
Platelet count increased
  • 5.12% for females aged 50 (±5) who take Ceftin
Pleural effusion
  • 12.37% for females aged 50 (±5) who take Ceftin
Pneumonia
  • 9.59% for females aged 50 (±5) who take Ceftin
Poor dental condition
  • 6.4% for females aged 50 (±5) who take Ceftin
Pulpitis dental
  • 5.97% for females aged 50 (±5) who take Ceftin
Rashes
  • 5.76% for females aged 50 (±5) who take Ceftin
Rotator cuff syndrome
  • 6.18% for females aged 50 (±5) who take Ceftin
Sepsis
  • 6.61% for females aged 50 (±5) who take Ceftin
Spinal osteoarthritis
  • 6.4% for females aged 50 (±5) who take Ceftin
Stomatitis
  • 6.18% for females aged 50 (±5) who take Ceftin
Stress and anxiety
  • 15.35% for females aged 50 (±5) who take Ceftin
Swallowing difficulty
  • 5.76% for females aged 50 (±5) who take Ceftin
Swelling
  • 7.25% for females aged 50 (±5) who take Ceftin
Swelling face
  • 7.25% for females aged 50 (±5) who take Ceftin
Systemic lupus erythematosus
  • 6.82% for females aged 50 (±5) who take Ceftin
Systemic sclerosis (scleroderma)
  • 6.4% for females aged 50 (±5) who take Ceftin
Thrombocytosis
  • 7.46% for females aged 50 (±5) who take Ceftin
Tooth abscess
  • 6.82% for females aged 50 (±5) who take Ceftin
Tooth disorder
  • 5.97% for females aged 50 (±5) who take Ceftin
Tooth extraction
  • 6.82% for females aged 50 (±5) who take Ceftin
Tooth injury
  • 6.18% for females aged 50 (±5) who take Ceftin
Traumatic injury of the bladder and urethra
  • 5.97% for females aged 50 (±5) who take Ceftin
Tricuspid valve incompetence
  • 7.25% for females aged 50 (±5) who take Ceftin
Tympanic membrane disorder
  • 5.97% for females aged 50 (±5) who take Ceftin
Ulcerative colitis
  • 6.4% for females aged 50 (±5) who take Ceftin
Urine output - decreased
  • 5.97% for females aged 50 (±5) who take Ceftin
Uterine leiomyoma
  • 5.97% for females aged 50 (±5) who take Ceftin
Vasculitis
  • 5.97% for females aged 50 (±5) who take Ceftin
Vitreous detachment
  • 5.33% for females aged 50 (±5) who take Ceftin
Weakness
  • 9.38% for females aged 50 (±5) who take Ceftin
Wegener's granulomatosis
  • 5.97% for females aged 50 (±5) who take Ceftin
Weight decreased
  • 7.68% for females aged 50 (±5) who take Ceftin
  • 7.65% for females aged 50 (±5) who take Metformin hydrochloride
Wound infection staphylococcal
  • 5.97% for females aged 50 (±5) who take Ceftin

Most common co-existing conditions:

Depression
  • 6.03% for females aged 50 (±5) who take Metformin hydrochloride
High blood cholesterol
  • 8.79% for females aged 50 (±5) who take Metformin hydrochloride
High blood pressure
  • 12.25% for females aged 50 (±5) who take Metformin hydrochloride
Osteoporosis
  • 7.25% for females aged 50 (±5) who take Ceftin
Pain
  • 5.54% for females aged 50 (±5) who take Ceftin
Rheumatoid arthritis
  • 5.54% for females aged 50 (±5) who take Metformin hydrochloride
Systemic lupus erythematosus
  • 5.97% for females aged 50 (±5) who take Ceftin
back to top

Males aged 50 to 59 :

21,279 related reports were analyzed:

Most common symptoms:

Acute myocardial infarction
  • 6.25% for males aged 50 (±5) who take Ceftin
Anaemia
  • 5.83% for males aged 50 (±5) who take Ceftin
Blood bilirubin increased
  • 5.0% for males aged 50 (±5) who take Ceftin
Blood glucose increased
  • 8.5% for males aged 50 (±5) who take Metformin hydrochloride
Carpal tunnel syndrome
  • 5.42% for males aged 50 (±5) who take Ceftin
Cellulitis
  • 7.08% for males aged 50 (±5) who take Ceftin
Chest pain
  • 6.25% for males aged 50 (±5) who take Ceftin
Chills
  • 6.25% for males aged 50 (±5) who take Ceftin
Coronary heart disease
  • 7.92% for males aged 50 (±5) who take Ceftin
Cough
  • 13.75% for males aged 50 (±5) who take Ceftin
Coughing up blood
  • 6.67% for males aged 50 (±5) who take Ceftin
Dehydration
  • 10.0% for males aged 50 (±5) who take Ceftin
Depression
  • 10.83% for males aged 50 (±5) who take Ceftin
Diarrhea
  • 5.83% for males aged 50 (±5) who take Ceftin
Drug dependence
  • 5.83% for males aged 50 (±5) who take Ceftin
Drug withdrawal syndrome
  • 6.67% for males aged 50 (±5) who take Ceftin
Emotional distress
  • 11.25% for males aged 50 (±5) who take Ceftin
Fatigue
  • 14.58% for males aged 50 (±5) who take Ceftin
Fever
  • 14.17% for males aged 50 (±5) who take Ceftin
Gastroesophageal reflux disease
  • 5.83% for males aged 50 (±5) who take Ceftin
Headache
  • 10.0% for males aged 50 (±5) who take Ceftin
Heart attack
  • 9.17% for males aged 50 (±5) who take Ceftin
  • 5.42% for males aged 50 (±5) who take Metformin hydrochloride
High blood cholesterol
  • 5.0% for males aged 50 (±5) who take Ceftin
High blood pressure
  • 10.42% for males aged 50 (±5) who take Ceftin
Hypotension
  • 6.25% for males aged 50 (±5) who take Ceftin
Infectious mononucleosis
  • 6.25% for males aged 50 (±5) who take Ceftin
Injury
  • 7.92% for males aged 50 (±5) who take Ceftin
Insomnia
  • 7.08% for males aged 50 (±5) who take Ceftin
Itching
  • 11.67% for males aged 50 (±5) who take Ceftin
Joint pain
  • 9.17% for males aged 50 (±5) who take Ceftin
Jugular vein thrombosis
  • 6.67% for males aged 50 (±5) who take Ceftin
Leukocytosis
  • 7.5% for males aged 50 (±5) who take Ceftin
Mitral valve incompetence
  • 5.42% for males aged 50 (±5) who take Ceftin
Mitral valve prolapse
  • 5.42% for males aged 50 (±5) who take Ceftin
Muscle cramps
  • 5.42% for males aged 50 (±5) who take Ceftin
Nausea
  • 6.88% for males aged 50 (±5) who take Metformin hydrochloride
  • 5.0% for males aged 50 (±5) who take Ceftin
Oedema peripheral
  • 7.92% for males aged 50 (±5) who take Ceftin
Pain
  • 7.08% for males aged 50 (±5) who take Ceftin
Pain in extremity
  • 8.33% for males aged 50 (±5) who take Ceftin
Pleural effusion
  • 7.5% for males aged 50 (±5) who take Ceftin
Pneumonia
  • 6.25% for males aged 50 (±5) who take Ceftin
Pollakiuria
  • 7.92% for males aged 50 (±5) who take Ceftin
Pseudomonal sepsis
  • 5.83% for males aged 50 (±5) who take Ceftin
Pulmonary congestion
  • 6.67% for males aged 50 (±5) who take Ceftin
Pulmonary embolism
  • 5.0% for males aged 50 (±5) who take Ceftin
Rash erythematous
  • 7.08% for males aged 50 (±5) who take Ceftin
Rashes
  • 10.0% for males aged 50 (±5) who take Ceftin
Renal failure acute
  • 6.25% for males aged 50 (±5) who take Ceftin
Sleep apnea syndrome
  • 5.83% for males aged 50 (±5) who take Ceftin
Squamous cell carcinoma
  • 5.42% for males aged 50 (±5) who take Ceftin
Stable angina
  • 5.42% for males aged 50 (±5) who take Ceftin
Stress and anxiety
  • 12.08% for males aged 50 (±5) who take Ceftin
Thrombosis
  • 7.92% for males aged 50 (±5) who take Ceftin
Trigger finger
  • 5.42% for males aged 50 (±5) who take Ceftin
Weakness
  • 5.83% for males aged 50 (±5) who take Ceftin
Weight decreased
  • 5.53% for males aged 50 (±5) who take Metformin hydrochloride
  • 5.42% for males aged 50 (±5) who take Ceftin

Most common co-existing conditions:

High blood cholesterol
  • 9.15% for males aged 50 (±5) who take Metformin hydrochloride
High blood pressure
  • 13.3% for males aged 50 (±5) who take Metformin hydrochloride
back to top

Do you take Ceftin and Metformin hydrochloride:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Ceftin

Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. (latest outcomes from Ceftin 3,645 users)

Metformin hydrochloride

Metformin hydrochloride has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Metformin hydrochloride 25,529 users)

General study

Related publications that referenced our studies


Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!